AzTrials
AzTrials

Mechanical VentilationPhase 2RESCUENCT00663637

Removal of Endotracheal Tube Secretions Comprehensively Until Extubation

A Phase 2 study testing CAM (Complete Airway Management) Catheters in people with Mechanical Ventilation and Pneumonia, run by O. M. Neotech, Inc. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to measure secretion accumulation within endotracheal tubes of mechanically ventilated patients and test the efficacy, safety and clinical impact of removing the secretions using novel airway management catheters (Complete Airway Management Catheters: CAM Rescue Cath and CAM Endotrach… Read more about this study

Who is it for?
Any age
Conditions the study is for
Mechanical Ventilation, Pneumonia
What is being tested?
CAM (Complete Airway Management) Catheters
Type of treatment
Medical device
How many people
30 participants
Where
1 siteUnited States
Study dates
Apr 2008to not given
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients receiving medical care in adult intensive care unit setting
  • Patients who have been intubated and mechanically ventilated for at least 12 hours
  • Patients intubated with an endotracheal tube with an internal diameter of 7.0 mm or greater

Who cannot join

  • Patients receiving medical care in a setting not compatible with an adult intensive care unit
  • Patients who have been intubated and mechanically ventilated for less than 12 hours
  • Patients intubated with an endotracheal tube with an internal diameter of 6.5 mm or less
  • Patients intubated with dual lumen or steel-reinforced endotracheal tubes

Trial locations and contacts

1 site in 1 country.

Robert H. Stone, RRT contact

573-331-3000 ext. 6393

bstone@sfmc.net

Stephen S. Bricknell, RRT contact

573-331-3000 ext. 6393

sbricknell@sfmc.net

United States1 site, 1 recruiting
  • Saint Francis Medical Center

    Cape Girardeau, Missouri, 63703

    Robert H. Stone, RRT

    Stephen S. Bricknell, RRT

    Recruiting

Other trials in United States

About this study

Official title: Evaluation of the Safety and Efficacy of CAM (Complete Airway Management) Catheters: Phase II Study

The purpose of this study is to measure secretion accumulation within endotracheal tubes of mechanically ventilated patients and test the efficacy, safety and clinical impact of removing the secretions using novel airway management catheters (Complete Airway Management Catheters: CAM Rescue Cath and CAM Endotrach Cath).

Read the detailed description

Thirty mechanically ventilated adult patients will be managed with standard suction catheters. Just prior to extubation, their physiological parameters (including work of breathing) will be recorded and acoustic reflectometry used to measure the degree of secretion accumulation within the endotracheal tube. The endotracheal tubes will then be cleaned using the CAM Catheters (Rescue Cath followed by Endotrach Cath) and the physiological parameters and endotracheal tube reflectometry measurements repeated for comparative analysis.

Being tested
CAM (Complete Airway Management) Catheters
Keywords
endotracheal tube obstruction, occlusion, mechanical ventilation, complication, work of breathing, airway resistance, secretions, pneumonia, ventilator associated, biofilms, endotracheal tube
Medical subject headings
Pneumonia, Bites and Stings, Pneumonia, Ventilator-Associated

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CAM (Complete Airway Management) CathetersDevice

    Also called CAM Rescue Cath, CAM Endotrach Cath

    Prior to extubation, endotracheal tube lumen secretions are mechanically removed using CAM Rescue Cath followed by CAM Endotrach Cath.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. work of breathing

    Measured: pre-extubation

Secondary outcomes (1)
  1. endotracheal tube patency

    Measured: pre-extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2008 (estimated)
  2. Study startApr 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00663637
Sponsor's protocol ID
CAM-0801
Acronym
RESCUE
Status last verified
Apr 2008
First submitted
18 Apr 2008
Last updated
29 May 2008
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing CAM (Complete Airway Management) Catheters in people with Mechanical Ventilation and Pneumonia, run by O. M. Neotech, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 May 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Robert H. Stone, RRT (573-331-3000 ext. 6393, bstone@sfmc.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

work of breathing (time frame: pre-extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in